AN2 Therapeutics (ANTX) Treasury Shares (2024 - 2026)

AN2 Therapeutics (ANTX) has 3 years of Treasury Shares data on file, last reported at $1.3 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $1.3 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (changed N/A YoY), and the FY2025 annual result was $856160.0, up 65.76% from the prior year.
• Treasury Shares improved to $1.3 million in Q1 2026 per ANTX's latest filing, from $856160.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $1.3 million in Q1 2026 and troughed at $458246.0 in Q1 2024.
• A 3-year average of $724593.9 and a median of $624719.0 in 2024 frame the typical range for Treasury Shares.
• On a YoY basis, Treasury Shares climbed as much as 84.85% in 2025 and fell as far as 65.76% in 2025.
• A 3-year view of Treasury Shares shows it stood at $516511.0 in 2024, then jumped by 65.76% to $856160.0 in 2025, then surged by 48.97% to $1.3 million in 2026.
• Business Quant data shows ANTX's Treasury Shares at $1.3 million in Q1 2026, $856160.0 in Q4 2025, and $870300.0 in Q3 2025.